These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 15181136
1. Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging. Chung JH, Cho KJ, Lee SS, Baek HJ, Park JH, Cheon GJ, Choi CW, Lim SM. J Nucl Med; 2004 Jun; 45(6):999-1003. PubMed ID: 15181136 [Abstract] [Full Text] [Related]
2. GLUT1 expression in tissue and (18)F-FDG uptake. Avril N. J Nucl Med; 2004 Jun; 45(6):930-2. PubMed ID: 15181126 [No Abstract] [Full Text] [Related]
3. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study. Higashi K, Ito K, Hiramatsu Y, Ishikawa T, Sakuma T, Matsunari I, Kuga G, Miura K, Higuchi T, Tonami H, Yamamoto I. J Nucl Med; 2005 Feb; 46(2):267-73. PubMed ID: 15695786 [Abstract] [Full Text] [Related]
4. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma? Sivrikoz CM, Ak I, Simsek FS, Döner E, Dündar E. Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019 [Abstract] [Full Text] [Related]
5. [Correlation between SUV of (18)F-FDG PET-CT and the expression of GLUT1, MVD and Ki67 in non-small cell lung cancer]. Duan Y, Yu LJ, Lu PO, Wang WZ. Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):764-7. PubMed ID: 19173807 [Abstract] [Full Text] [Related]
6. Comparison of GLUT-1, SGLT-1, and SGLT-2 expression in false-negative and true-positive lymph nodes during the 18F-FDG PET/CT mediastinal nodal staging of non-small cell lung cancer. Taira N, Atsumi E, Nakachi S, Takamatsu R, Yohena T, Kawasaki H, Kawabata T, Yoshimi N. Lung Cancer; 2018 Sep; 123():30-35. PubMed ID: 30089592 [Abstract] [Full Text] [Related]
7. [Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non-small cell lung cancer]. Yang WF, Tan GZ, Fu Z, Yu JM. Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):925-8. PubMed ID: 20193335 [Abstract] [Full Text] [Related]
8. 18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles. Nakagawa T, Yamada M, Suzuki Y. J Nucl Med; 2008 Jul; 49(7):1053-9. PubMed ID: 18587087 [Abstract] [Full Text] [Related]
9. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer]. Hu M, Yu JM, Liu NB, Liu LP, Guo HB, Yang GR, Zhang PL, Xu XQ. Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639 [Abstract] [Full Text] [Related]
10. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? Hellwig D, Graeter TP, Ukena D, Groeschel A, Sybrecht GW, Schaefers HJ, Kirsch CM. J Nucl Med; 2007 Nov; 48(11):1761-6. PubMed ID: 17942814 [Abstract] [Full Text] [Related]
12. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high. Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, Erelel M, Ece T, Mudun A. Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432 [Abstract] [Full Text] [Related]
13. Increasing the accuracy of 18F-FDG PET/CT interpretation of "mildly positive" mediastinal nodes in the staging of non-small cell lung cancer. Moloney F, Ryan D, McCarthy L, McCarthy J, Burke L, Henry MT, Kennedy MP, Hinchion J, McSweeney S, Maher MM, O'Regan K. Eur J Radiol; 2014 May; 83(5):843-7. PubMed ID: 24581594 [Abstract] [Full Text] [Related]
14. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. Yen TC, See LC, Lai CH, Yah-Huei CW, Ng KK, Ma SY, Lin WJ, Chen JT, Chen WJ, Lai CR, Hsueh S. J Nucl Med; 2004 Jan; 45(1):22-9. PubMed ID: 14734665 [Abstract] [Full Text] [Related]
16. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Takamochi K, Yoshida J, Murakami K, Niho S, Ishii G, Nishimura M, Nishiwaki Y, Suzuki K, Nagai K. Lung Cancer; 2005 Feb; 47(2):235-42. PubMed ID: 15639722 [Abstract] [Full Text] [Related]
17. FDG-PET in staging lung cancer: how does it change the algorithm? Verhagen AF, Bootsma GP, Tjan-Heijnen VC, van der Wilt GJ, Cox AL, Brouwer MH, Corstens FH, Oyen WJ. Lung Cancer; 2004 May; 44(2):175-81. PubMed ID: 15084382 [Abstract] [Full Text] [Related]
18. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer. Muto J, Hida Y, Kaga K, Ohtaka K, Okamoto S, Tamaki N, Nakada-Kubota R, Hirano S, Matsui Y. Anticancer Res; 2014 Feb; 34(2):805-10. PubMed ID: 24511016 [Abstract] [Full Text] [Related]
19. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Kim YK, Lee KS, Kim BT, Choi JY, Kim H, Kwon OJ, Shim YM, Yi CA, Kim HY, Chung MJ. Cancer; 2007 Mar 15; 109(6):1068-77. PubMed ID: 17311309 [Abstract] [Full Text] [Related]
20. FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer. Chung JH, Lee WW, Park SY, Choe G, Sung SW, Chung JK, Lee MC, Kim SE. Eur J Surg Oncol; 2006 Nov 15; 32(9):989-95. PubMed ID: 16859874 [Abstract] [Full Text] [Related] Page: [Next] [New Search]